Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)

October 2, 2008 | Comments Off on Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)

Therapeutics and Clinical Risk Management. 2008 Jun;4(3):579-85. [Link] Felip E, Rosell R. Vall d’Hebron University Hospital Barcelona, Spain. Abstract NSCLC accounts for 80% of all cases of lung cancer, which…

Acrylamide Carcinogenicity

September 30, 2008 | Comments Off on Acrylamide Carcinogenicity

Journal of Agricultural and Food Chemistry. 2008;61:1119-1121. [Link] Klaunig JE. Department of Pharmacology and Toxicology, Center for Environmental Health, Indiana University School of Medicine, MS A503, 635 Barnhill Drive, Indianapolis,…

Mesothelial reaction in longstanding Crohn’s ileitis simulating papillary mesothelioma

September 30, 2008 | Comments Off on Mesothelial reaction in longstanding Crohn’s ileitis simulating papillary mesothelioma

Journal of Clinical Pathology. 2008;61:1119-1121. [Link] Wilkinson L, De P, Bloxham C. University Hospital of North Durham, North Road, Durham, UK. lsarkar@talk21.com Abstract Intestinal and extraintestinal complications of Crohn’s disease…

Treatment of peritoneal mesothelioma in pediatric patients

September 27, 2008 |

Pediatric Blood & Cancer. 2009 Jan;52(1):127-9. [Link] Cioffredi LA, Jänne PA, Jackman DM. Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. Abstract Peritoneal mesothelioma is a rare and often aggressive malignancy,…

The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case–control study in the city of Bari (Italy)

September 24, 2008 | Comments Off on The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case–control study in the city of Bari (Italy)

International Archives of Occupational and Environmental Health. 2008 Sep 23. [Epub ahead of print] [Link] Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. Department of Internal Medicine and…

Pleural fluid findings as prognostic factors for malignant pleural mesothelioma

September 23, 2008 | Comments Off on Pleural fluid findings as prognostic factors for malignant pleural mesothelioma

Journal of Clinical Laboratory Analysis. 2008;22(5):334-6. [Link] Flores RM, Routledge T, Seshan VE, Dycoco J, Zakowski M, Hirth Y, Rusch VW. Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center,…

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system

September 23, 2008 | Comments Off on The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system

The Journal of Thoracic and Cardiovascular Surgery. 2008 Sep;136(3):605-10. Epub 2008 Jun 27. [Link] Flores RM, Routledge T, Seshan VE, Dycoco J, Zakowski M, Hirth Y, Rusch VW. Thoracic Service,…

Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia

September 23, 2008 | Comments Off on Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia

Occupational and Environmental Medicine. 2008 Sep 19. [Epub ahead of print] [Link] Reid A, Berry G, Heyworth JS, de Klerk N, Musk AB. University of Western Australia, Australia Abstract Introduction:…

Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer

September 19, 2008 | Comments Off on Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer

Lung Cancer. 2008 Sep 15. [Epub ahead of print] [Link] Pedretti M, Soltermann A, Arni S, Weder W, Neri D, Hillinger S. Department of Chemistry and Applied Biosciences, ETH Zurich,…

Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy

September 19, 2008 | Comments Off on Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy

European Journal of Cardio-Thoracic Surgery. 2008 Nov;34(5):1090-6. Epub 2008 Sep 16. [Link] Sørensen JB, Ravn J, Loft A, Brenøe J, Berthelsen AK; Nordic Mesothelioma Group. Aaseboe U, Billing B, Bjørck…

Categories